For instance, in pathological conditions such as diabetes, ischemia, or inflammation, disruptions in cellular metabolism could impair the activity of RNF213 and its ability to regulate Cav-1, leading to endothelial dysfunction and promoting vascular abnormalities. This evidence concerns the gene RNF213 and diabetes mellitus.